|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-3
|
|
pubmed:abstractText |
Schizophrenia is a chronic disease that is treated with dopamine antagonists. These drugs can produce intolerable side effects through their blockade of central nervous system dopamine receptors unrelated to schizophrenia. The atypical antipsychotic aripiprazole, a dopamine receptor partial agonist, has mixed agonist-antagonist effects. Its partial agonism is said to protect the patient from the side effects caused by full antagonists at the same time that its antagonism treats the schizophrenia effectively.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1537-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
173-5
|
|
pubmed:meshHeading |
pubmed-meshheading:18520984-Adult,
pubmed-meshheading:18520984-Antipsychotic Agents,
pubmed-meshheading:18520984-Dose-Response Relationship, Drug,
pubmed-meshheading:18520984-Drug Therapy, Combination,
pubmed-meshheading:18520984-Hallucinations,
pubmed-meshheading:18520984-Haloperidol,
pubmed-meshheading:18520984-Humans,
pubmed-meshheading:18520984-Male,
pubmed-meshheading:18520984-Piperazines,
pubmed-meshheading:18520984-Prolactin,
pubmed-meshheading:18520984-Quinolones,
pubmed-meshheading:18520984-Schizophrenia,
pubmed-meshheading:18520984-Schizophrenic Psychology,
pubmed-meshheading:18520984-Treatment Outcome
|
|
pubmed:articleTitle |
Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
|
|
pubmed:affiliation |
Department of Psychiatry, Lotung St. Mary's Hospital, Ilan, Taiwan. kuo2084@yahoo.com.tw
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
